A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants

NCT01309386 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Tapentadol ER
DRUG: Morphine SR

Sponsor

Janssen Pharmaceutical K.K.